Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: A suicide assessment methodology study report

10.1097/JCP.0b013e3181dbfd04Journal of Clinical Psychopharmacology303259-266JCPY

Assessing anxious features in depressed outpatients

10.1002/mpr.353International Journal of Methods in Psychiatric Research204e69-e82IPSR

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study

10.1176/appi.ajp.2011.10111645American Journal of Psychiatry1687689-701AJPS

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report

10.1016/j.jad.2011.04.032Journal of Affective Disorders1333467-476JADI